Menu
Telegram chat:
@cpa_house
Got questions?
Telegram chat
@cpa_house

Offers

Filters

Tier
Payouts currency
Additionally

Offers found 6433

Temporarily stopped.

Premium Vision (ES)
Premium Vision (ES)
Organs of vision health product.
ID: 5921
Not active
Create flow
CR
Approval Rate
Category Vision
Country Temporarily stopped.

Temporarily stopped.

Premium Vision (HU)
Premium Vision (HU)
Organs of vision health product.
ID: 5920
Not active
Create flow
CR
Approval Rate
Category Vision
Country Temporarily stopped.

Temporarily stopped.

Sentun Immune (BE)
Sentun Immune (BE)
Immunity boost product.
ID: 5919
Not active
Create flow
CR
Approval Rate
Category Immunity
Country Temporarily stopped.
Flexosamine Low Price (LT)
Flexosamine Low Price (LT)
Joints health product.
ID: 5918
Active
Create flow
CR
Approval Rate
Category Joints
Country Lithuania
Price 29 €
Payout 19 $
Cryo Size Low Price (UA)
Cryo Size Low Price (UA)
Weight regulation product.
ID: 5917
Active
Create flow
CR 17.65%
Approval Rate 50%
Category Weight loss
Country Ukraine
Price 37 грн
Payout 15 $
Neoprostan Free (UA)
Neoprostan Free (UA)
Prostate gland health product.
ID: 5916
Active
Create flow
CR 6.59%
Approval Rate 23.53%
Category Prostatitis
Country Ukraine
Price 0 грн
Payout 16 $
Idealis (ES)
Idealis (ES)
Weight regulation product.
ID: 5915
Active
Create flow
CR
Approval Rate
Category Weight loss
Country Spain
Price 39 €
Payout 31 $
Neoprostan Low Price (UA)
Neoprostan Low Price (UA)
Prostate gland health product.
ID: 5914
Active
Create flow
CR 20.26%
Approval Rate 6.45%
Category Prostatitis
Country Ukraine
Price 44 грн
Payout 16 $
Ketoferol Low Price (BG)
Ketoferol Low Price (BG)
Weight regulation product.
ID: 5913
Active
Create flow
CR 2.63%
Approval Rate 100%
Category Weight loss
Country Bulgaria
Price 38 лев
Payout 14 $

Temporarily stopped.

Presuren Cardio Low Price (PL)
Presuren Cardio Low Price (PL)
Product for managing high blood pressure.
ID: 5912
Not active
Create flow
CR
Approval Rate
Category Hypertension
Country Temporarily stopped.